Table 1 General clinical features of enrolled patients
HIV+/HCV+ | HIV−/HCV+ | p-value | |
|---|---|---|---|
Patients, n | 5 | 11 | |
Sex, n (%) | |||
Male | 5 (100) | 8 (72.73) | 0.509 |
Female | 0 | 3 (27.27) | |
Age (years) | |||
Mean ± SD (min; max) | 53.2 ± 4.66 (49; 60) | 62.54 ± 10.27 (48; 79) | 0.076 |
Median (25°; 75°) | 51 (50; 56) | 62 (64; 70.5) | |
ECOG PS, n (%) | |||
0 | 5 (100) | 8 (72.72) | 0.509 |
1 | 0 (0) | 3 (27.27) | |
Comorbidities, n (%) | |||
Diabetes | 1 (20) | 1 (9.09) | 0.99 |
Heart failure | 0 | 1 (9.09) | 0.99 |
Chronic kidney disease | 0 | 0 | 1 |
Respiratory insufficiency | 0 | 3 (27.27) | 0.509 |
Previous abdominal surgery | 2 (40) | 7 (63.63) | 0.596 |
Charlson comorbidity index | |||
Mean ± SD (min; max) | 4.8 ± 1.09 (4; 6) | 5.36 ± 1.36 (3; 8) | 0.447 |
Median (25°; 75°, %) | 4 (4; 6) | 5 (5; 6) | |
< 7 | 6 (100) | 9 (81.81) | 0.515 |
≥ 7 | 0 | 2 (18.18) | |
ASA score, n (%) | |||
1 | 0 | 1 (9.09) | 0.99 |
2 | 4 (80) | 8 (72.72) | |
3 | 1 (20) | 2 (18.18) | |
Cirrhosis, n (%) | 4 (80) | 9 (81.81) | 0.99 |
Child-Pugh class, n (%) | |||
A | 4 (80) | 11 (100) | |
B | 1 (20) | 0 | 0.315 |
C | 0 | 0 | |
MELD | |||
Mean ± SD (min; max) | 9 ± 2.82 (6; 12) | 9.18 ± 2.4 (7; 14) | 0.895 |
Median (25°; 75°, %) | 8 (7; 12) | 8 (8; 10) | |
AFP ng/mL, n (%) | |||
≤ 20 | 4 (100) | 4 (40) | 0.085 |
> 20 | 0 | 6 (60) | |
HCV treatment response, n (%) | |||
SVR | 4 (80) | 10 (90.9) | 0.99 |
Non-SVR | 1 (20) | 1 (9.09) | |
Number of nodules at imaging, n | 5 | 15 | |
Mean (range) | 1 (1; 1) | 1.36 (1; 3) | 0.244 |
Largest nodule diameter at imaging (mm) | |||
Mean ± SD | 26.4 ± 14.2 | 29.3 ± 11 | 0.57 |
Portal vein thrombosis, n (%) | 0 | 1 (9.09) | 0.99 |
BCLC stage, n (%) | |||
0-A | 5 (100) | 9 (81.81) | 0.99 |
B-C | 0 | 2 (18.18) | |
Milan criteria, n (%) | |||
Out | 0 (0) | 2 (18.18) | 0.99 |
In | 5 (100) | 9 (81.81) | |